Home » Topics » BioWorld Science

BioWorld Science
RSS

Tokyo Tanabe discloses agents for the treatment of diarrhea

Oct. 18, 1996

LTA4 hydrolase inhibitor effective in ulcerative colitis

Oct. 18, 1996

Astra-CSL collaboration for H. pylori immunotherapeutic

Oct. 18, 1996

Gastric antisecretory agents disclosed by Il-Yang

Oct. 18, 1996

New alternative available for BPH

Oct. 18, 1996

Merck persists in the search for BPH therapeutics

Oct. 18, 1996

Servier selects TxA2 antagonist for further study

Oct. 18, 1996

Antiplatelet agents from Taisho

Oct. 18, 1996

Antithrombotic prostaglandin analogue revealed by Asahi Glass

Oct. 18, 1996

BASF reports on novel thrombin inhibitors

Oct. 18, 1996

Popular Stories

News in brief
BioWorld Asia
BioWorld Asia briefs for April 28, 2026
Bio Korea 2026 kicks off with spotlight on oligonucleotides
BioWorld
Three decades of trial-and-error, and the resulting safety data, in the oligonucleotide-based therapeutic space have paved way for the present-day innovations and...
Chinese biotechs gain leverage as partners in dealmaking
BioWorld
China’s biotech ecosystem has crossed an inflection point, and Chinese biotechs are gaining leverage in dealmaking, executives from multinational companies said...
University of Western Australia patents 5-HT2A/B modulators
BioWorld Science
University of Western Australia has identified new lysergic acid diethylamide (LSD) analogues acting as 5-HT2A and 5-HT2B modulators reported to be useful for the...
AA meeting of minds as PTC, Novartis push votoplam in HD
BioWorld
What PTC Therapeutics Inc.’s latest data with votoplam might mean in the Huntington’s disease (HD) landscape became grist for Wall Street after the firm unveiled...